Variable | Sub category | Rate Per 100 *PYO | Unadjusted HR (95% CI) | ƒLRT p-value | Adjusted HR (95% CI) for all variables | £p-value |
---|---|---|---|---|---|---|
Overall | – | 11.9 | ||||
Sex | Male | 12.8 | 1.00 | 0.612 | 1.00 | |
Female | 11.7 | 0.94 (0.75–0.1.18) | 1.19 (0.94–1.53) | 0.155 | ||
Age (years) | 10–17 | 15.2 | 1.00 | 0.018 | 1.00 | |
18–24 | 11.4 | 0.76 (0.61–0.95) | 0.78 (0.62–0.98) | 0.032 | ||
WHO stage | l | 7.7 | 1.00 | < 0.001 | 1.00 | |
ll | 13.3 | 1.72 (1.37–2.16) | 1.34 (1.06–1.70) | 0.014 | ||
lll | 17.7 | 2.25 (1.85–2.73) | 1.73 (1.40–2.14) | < 0.001 | ||
lV | 19.4 | 2.46 (1.88–3.21) | 2.09 (1.58–2.77) | < 0.001 | ||
ART status at entry into clinic | Naive | 12.0 | 1.00 | 0.121 | ||
Experienced | 7.5 | 0.60 (0.30–1.21) | ||||
Transfer status | Not transferred | 1.00 | < 0.001 | 1.00 | ||
Transferred out | 1.63 (1.27–2.08) | 1.42 (1.11–1.82) | 0.006 | |||
Baseline CD4 | < 250 | 16.1 | 1.00 | < 0.001 | 1.00 | |
250–499 | 6.0 | 0.38 (0.30–0.47) | 0.51 (0.40–0.66) | < 0.001 | ||
500 + | 3.3 | 0.21 (0.13–0.36) | 0.29 (0.17–0.49) | < 0.001 | ||
Year of ART initiation | Before 2010 | 19.0 | 1.00 | < 0.001 | 1.00 | |
2010 + | 8.8 | 0.46 (0.39–0.55) | 0.97 (0.79–1.19) | 0.777 | ||
NNRTI/PI based | NVP | 22.5 | 1.00 | < 0.001 | 1.00 | |
EFV | 10.1 | 0.45 (0.38–0.55) | 0.62 (0.50–0.76) | |||
LPV/r | 13.5 | 0.59 (0.39–0.89) | 0.62 (0.41–0.94) | < 0.001 | ||
ATV/r | 13.7 | 0.57 (0.14–2.29) | 0.48 (0.12–1.97) | 0.310 |